🇺🇸 FDA
Patent

US 10322125

TGF-beta enhancing compositions for cartilage repair and methods related thereto

granted A61KA61K31/15A61K31/357

Quick answer

US patent 10322125 (TGF-beta enhancing compositions for cartilage repair and methods related thereto) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veteran Affairs
Grant date
Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/15, A61K31/357, A61K31/404, A61K31/47